{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:57:20Z","timestamp":1793977040807,"version":"4.8.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007924","name":"Bengbu Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018628","name":"Scientific Research Foundation of Education Department of Anhui Province of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018628","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.biopha.2021.111342","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T07:40:37Z","timestamp":1612942837000},"page":"111342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Advances in the research of nanodrug delivery system for targeted treatment of liver fibrosis"],"prefix":"10.1016","volume":"137","author":[{"given":"Wei","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2021.111342_bib1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5152\/tjg.2018.17330","article-title":"Liver fibrosis","volume":"29","author":"Aydin","year":"2018","journal-title":"Turk. J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.biopha.2021.111342_bib2","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","article-title":"Pathobiology of liver fibrosis: a translational success story","volume":"64","author":"Lee","year":"2015","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.biopha.2021.111342_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bpg.2017.04.005","article-title":"Reversal of liver fibrosis: from fiction to reality","volume":"31","author":"Zoubek","year":"2017","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.biopha.2021.111342_bib4","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.3390\/nano10101945","article-title":"Recent advances in nanomedicine for the diagnosis and therapy of liver fibrosis","author":"Bai","year":"2020","journal-title":"Nanomaterials"},{"issue":"3","key":"10.1016\/j.biopha.2021.111342_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.15171\/mejdd.2018.103","article-title":"New concepts on reversibility and targeting of liver fibrosis; a review article","volume":"10","author":"Ebrahimi","year":"2018","journal-title":"Middle East J. Dig. Dis."},{"issue":"5","key":"10.1016\/j.biopha.2021.111342_bib6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1159\/000445269","article-title":"New developments on the treatment of liver fibrosis","volume":"34","author":"Koyama","year":"2016","journal-title":"Dig. Dis."},{"key":"10.1016\/j.biopha.2021.111342_bib7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.biopha.2017.01.107","article-title":"Sorafenib: a potential therapeutic drug for hepatic fibrosis and its outcomes","volume":"88","author":"Ma","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.biopha.2021.111342_bib8","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/01.cco.0000245316.82391.52","article-title":"Sorafenib","volume":"18","author":"Hahn","year":"2006","journal-title":"Curr. Opin. Oncol."},{"issue":"23","key":"10.1016\/j.biopha.2021.111342_bib9","doi-asserted-by":"crossref","first-page":"7242","DOI":"10.3748\/wjg.v20.i23.7242","article-title":"Nanotechnology applications for the therapy of liver fibrosis","volume":"20","author":"Giannitrapani","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.biopha.2021.111342_bib10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.dld.2004.11.009","article-title":"Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation","volume":"37","author":"Carpino","year":"2005","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.biopha.2021.111342_bib11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fphys.2012.00248","article-title":"Liver fibrogenesis in non-alcoholic steatohepatitis","volume":"3","author":"Bian","year":"2012","journal-title":"Front. Physiol."},{"issue":"8","key":"10.1016\/j.biopha.2021.111342_bib12","doi-asserted-by":"crossref","first-page":"570","DOI":"10.4254\/wjh.v6.i8.570","article-title":"Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver disease","volume":"6","author":"Giby","year":"2014","journal-title":"World J. Hepatol."},{"issue":"8","key":"10.1016\/j.biopha.2021.111342_bib13","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.4254\/wjh.v7.i8.1012","article-title":"Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease","volume":"7","author":"Souza-Mello","year":"2015","journal-title":"World J. Hepatol."},{"issue":"7","key":"10.1016\/j.biopha.2021.111342_bib14","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/jhbp.245","article-title":"Recent advancement of molecular mechanisms of liver fibrosis","volume":"22","author":"Seki","year":"2015","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2021.111342_bib15","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/hep.28948","article-title":"The origin of fibrogenic myofibroblasts in fibrotic liver","volume":"65","author":"Kisseleva","year":"2017","journal-title":"Hepatology"},{"issue":"32","key":"10.1016\/j.biopha.2021.111342_bib16","doi-asserted-by":"crossref","first-page":"E3297","DOI":"10.1073\/pnas.1400062111","article-title":"Origin of myofibroblasts in the fibrotic liver in mice","volume":"111","author":"Iwaisako","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.biopha.2021.111342_bib17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.diff.2016.07.001","article-title":"The characteristics of activated portal fibroblasts\/myofibroblasts in liver fibrosis","volume":"92","author":"Karin","year":"2016","journal-title":"Differentiation"},{"issue":"2","key":"10.1016\/j.biopha.2021.111342_bib18","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.stem.2017.07.011","article-title":"Mesenchymal stem cells in fibrotic disease","volume":"21","author":"El","year":"2017","journal-title":"Cell. Stem Cell."},{"key":"10.1016\/j.biopha.2021.111342_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2021.111342_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010024","article-title":"Metabolic hallmarks of hepatic stellate cells in liver fibrosis","volume":"9","author":"Khomich","year":"2019","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.biopha.2021.111342_bib21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12565-017-0395-9","article-title":"The stellate cell system (vitamin A-storing cell system)","volume":"92","author":"Senoo","year":"2017","journal-title":"Anat. Sci. Int."},{"issue":"1","key":"10.1016\/j.biopha.2021.111342_bib22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.5582\/bst.2018.01311","article-title":"Preoperative evaluation of the degree of liver fibrosis based on matter-element analysis using serological indicators in patients with hepatocellular carcinoma","volume":"13","author":"Liu","year":"2019","journal-title":"Biosci. Trends"},{"issue":"41","key":"10.1016\/j.biopha.2021.111342_bib23","doi-asserted-by":"crossref","first-page":"11567","DOI":"10.3748\/wjg.v21.i41.11567","article-title":"Non-invasive diagnosis of liver fibrosis and cirrhosis","volume":"21","author":"Lurie","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.biopha.2021.111342_bib24","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/ar.23567","article-title":"Basement membrane type IV collagen and laminin: an overview of their biology and value as fibrosis biomarkers of liver disease","volume":"300","author":"Mak","year":"2017","journal-title":"Anat. Rec."},{"issue":"3","key":"10.1016\/j.biopha.2021.111342_bib25","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cvsm.2016.11.007","article-title":"Getting the most out of liver biopsy","volume":"47","author":"Lidbury","year":"2017","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"issue":"2","key":"10.1016\/j.biopha.2021.111342_bib26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.5946\/ce.2018.049","article-title":"Endoscopic ultrasound real-time elastography in liver disease","volume":"51","author":"Song","year":"2018","journal-title":"Clin. Endosc."},{"issue":"1","key":"10.1016\/j.biopha.2021.111342_bib27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.rx.2017.09.003","article-title":"Imaging biomarkers in liver fibrosis","volume":"60","author":"Berzigotti","year":"2018","journal-title":"Radiologia"},{"issue":"3","key":"10.1016\/j.biopha.2021.111342_bib28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI30542","article-title":"Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ","volume":"117","author":"Iredale","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"32","key":"10.1016\/j.biopha.2021.111342_bib29","doi-asserted-by":"crossref","first-page":"23337","DOI":"10.1074\/jbc.M700194200","article-title":"Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition","volume":"282","author":"Zeisberg","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2021.111342_bib30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cellimm.2017.12.007","article-title":"Dynamic plasticity of macrophage functions in diseased liver","volume":"330","author":"Ritz","year":"2018","journal-title":"Cell Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2021.111342_bib31","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","article-title":"Macrophage heterogeneity in liver injury and fibrosis","volume":"60","author":"Tacke","year":"2014","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111342_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5582\/bst.2017.01007","article-title":"Key role of liver sinusoidal endothelial cells in liver fibrosis","volume":"11","author":"Xu","year":"2017","journal-title":"Biosci. Trends"},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2021.111342_bib33","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.clinre.2015.05.005","article-title":"Liver fibrosis: common mechanisms and antifibrotic therapies","volume":"39","author":"Schuppan","year":"2015","journal-title":"Clin. Res Hepatol. Gastroenterol."},{"key":"10.1016\/j.biopha.2021.111342_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s41232-016-0025-2","article-title":"Liver regeneration and fibrosis after inflammation","volume":"36","author":"Tanaka","year":"2016","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.biopha.2021.111342_bib35","first-page":"1129","article-title":"Kupffer cell-mediated hepatic injury induced by silica nanoparticles in vitro and in vivo","volume":"8","author":"Chen","year":"2013","journal-title":"Int J. Nanomed."},{"issue":"1","key":"10.1016\/j.biopha.2021.111342_bib36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"10","key":"10.1016\/j.biopha.2021.111342_bib37","doi-asserted-by":"crossref","first-page":"8767","DOI":"10.1021\/nn302502u","article-title":"Peptide-functionalized gold nanorods increase liver injury in hepatitis","volume":"6","author":"Bartneck","year":"2012","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.biopha.2021.111342_bib38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13205-020-2144-3","article-title":"Recent strategies towards the surface modification of liposomes: an innovative approach for different clinical applications","volume":"10","author":"Khan","year":"2020","journal-title":"3 Biotech"},{"issue":"7","key":"10.1016\/j.biopha.2021.111342_bib39","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3389\/fbioe.2019.00414","article-title":"Cytotoxicity-related bioeffects induced by nanoparticles: the role of surface chemistry","volume":"7","author":"Sun","year":"2019","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"6","key":"10.1016\/j.biopha.2021.111342_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201902561","article-title":"Ultrasmall BiOI quantum dots with efficient renal clearance for enhanced radiotherapy of cancer","volume":"7","author":"Wang","year":"2020","journal-title":"Adv. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2021.111342_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201702815","article-title":"Black phosphorus quantum dots with renal clearance property for efficient photodynamic therapy","volume":"14","author":"Guo","year":"2018","journal-title":"Small"},{"issue":"3","key":"10.1016\/j.biopha.2021.111342_bib42","first-page":"289","article-title":"Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives","volume":"2","author":"Uner","year":"2007","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.biopha.2021.111342_bib43","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/cmdc.200900502","article-title":"Silver nanoparticles mediate differential responses in keratinocytes and fibroblasts during skin wound healing","volume":"5","author":"Liu","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.biopha.2021.111342_bib44","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.biomaterials.2014.10.030","article-title":"Fluorescent cell-traceable dexamethasone-loaded liposomes for the treatment of inflammatory liver diseases","volume":"37","author":"Bartneck","year":"2015","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.biopha.2021.111342_bib45","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/gt.2013.41","article-title":"Inhibition of hepatic fibrosis with artificial microRNA using ultrasound and cationic liposome-bearing microbubbles","volume":"20","author":"Yang","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.biopha.2021.111342_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/7629724","article-title":"Clinical advancements in the targeted therapies against liver fibrosis","volume":"2016","author":"Bansal","year":"2016","journal-title":"Mediat. Inflamm."},{"issue":"2","key":"10.1016\/j.biopha.2021.111342_bib47","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00018-012-1046-x","article-title":"Peroxisome proliferator-activated receptor-gamma as a therapeutic target for hepatic fibrosis: from bench to bedside","volume":"70","author":"Zhang","year":"2013","journal-title":"Cell Mol. Life Sci."},{"issue":"11","key":"10.1016\/j.biopha.2021.111342_bib48","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/mt.2015.147","article-title":"Delivery of siRNA using CXCR4-targeted nanoparticles modulates tumor microenvironment and achieves a potent antitumor response in liver cancer","volume":"23","author":"Liu","year":"2015","journal-title":"Mol. Ther."},{"issue":"12","key":"10.1016\/j.biopha.2021.111342_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145512","article-title":"Effectiveness of losartan-loaded hyaluronic acid (HA) micelles for the reduction of advanced hepatic fibrosis in C3H\/HeN mice model","volume":"10","author":"Thomas","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2021.111342_bib50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/ijerph14010011","article-title":"Ameliorative effect of curcumin-encapsulated hyaluronic acid-PLA nanoparticles on thioacetamide-induced murine hepatic fibrosis","volume":"14","author":"Chen","year":"2016","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"3","key":"10.1016\/j.biopha.2021.111342_bib51","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1039\/C4GC01815J","article-title":"Evaluation of berberine\/bovine serum albumin nanoparticles for liver fibrosis therapy","volume":"17","author":"Lam","year":"2015","journal-title":"Green Chem."},{"issue":"2","key":"10.1016\/j.biopha.2021.111342_bib52","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1124\/jpet.105.099499","article-title":"The antiproliferative drug doxorubicin inhibits liver fibrosis in bile duct-ligated rats and can be selectively delivered to hepatic stellate cells in vivo","volume":"317","author":"Greupink","year":"2006","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.biopha.2021.111342_bib53","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jconrel.2015.11.003","article-title":"Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis","volume":"221","author":"Lin","year":"2016","journal-title":"J. Control. Release"},{"issue":"18","key":"10.1016\/j.biopha.2021.111342_bib54","doi-asserted-by":"crossref","first-page":"9012","DOI":"10.1039\/C3RA46093B","article-title":"Silymarin coated gold nanoparticles ameliorates CCl4-induced hepatic injury and cirrhosis through down regulation of hepatic stellate cells and attenuation of Kupffer cells","volume":"4","author":"Kabir","year":"2014","journal-title":"RSC Adv."},{"issue":"8","key":"10.1016\/j.biopha.2021.111342_bib55","first-page":"630","article-title":"Research progress of receptor targeted hepatic stellate cell in treatment of liver fibrosis","volume":"26","author":"Yang","year":"2018","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"38","key":"10.1016\/j.biopha.2021.111342_bib56","doi-asserted-by":"crossref","first-page":"62386","DOI":"10.18632\/oncotarget.11493","article-title":"Inhibition of insulin-like growth factor II (IGF-II)-dependent cell growth by multidentate pentamannosyl 6-phosphate-based ligands targeting the mannose 6-phosphate\/IGF-II receptor","volume":"7","author":"Zavorka","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.biopha.2021.111342_bib57","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1007\/s12035-016-9849-7","article-title":"Insulin-like growth factor-II\/cation-independent mannose 6-phosphate receptor in neurodegenerative diseases","volume":"54","author":"Wang","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111342_bib58","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1478-3231.2007.01452.x","article-title":"Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model","volume":"27","author":"Luk","year":"2007","journal-title":"Liver Int."},{"key":"10.1016\/j.biopha.2021.111342_bib59","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.biomaterials.2015.10.047","article-title":"Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis","volume":"76","author":"Kumar","year":"2016","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.biopha.2021.111342_bib60","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1034\/j.1600-0676.2001.210504.x","article-title":"Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin (M6P(28)-HSA)","volume":"21","author":"Beljaars","year":"2001","journal-title":"Liver"},{"key":"10.1016\/j.biopha.2021.111342_bib61","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cytogfr.2015.10.002","article-title":"The PDGF system and its antagonists in liver fibrosis","volume":"28","author":"Borkham-Kamphorst","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.biopha.2021.111342_bib62","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jconrel.2011.12.023","article-title":"Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor-beta on hepatic fibrosis in rats","volume":"159","author":"Li","year":"2012","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.biopha.2021.111342_bib63","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41419-020-2372-9","article-title":"Myofibroblast induces hepatocyte-to-ductal metaplasia via laminin\u2013\u0251v\u03b26 integrin in liver fibrosis","volume":"11","author":"Xu","year":"2020","journal-title":"Cell Death Dis."},{"issue":"31","key":"10.1016\/j.biopha.2021.111342_bib64","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.3748\/wjg.v18.i31.4199","article-title":"Oxymatrine liposome attenuates hepatic fibrosis via targeting hepatic stellate cells","volume":"18","author":"Chai","year":"2012","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111342_bib65","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1124\/jpet.107.122481","article-title":"Cyclic Arg-Gly-Asp peptide-labeled liposomes for targeting drug therapy of hepatic fibrosis in rats","volume":"322","author":"Du","year":"2007","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.biopha.2021.111342_bib66","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-94-024-0945-1_4","article-title":"Vitamin A absorption, storage and mobilization","volume":"81","author":"Blaner","year":"2016","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.biopha.2021.111342_bib67","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jconrel.2018.05.021","article-title":"Oral vitamin-A-coupled valsartan nanomedicine: high hepatic stellate cell receptors accessibility and prolonged enterohepatic residence","volume":"283","author":"El-Mezayen","year":"2018","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2021.111342_bib68","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2018.05.032","article-title":"Vitamin A-decorated biocompatible micelles for chemogene therapy of liver fibrosis","volume":"283","author":"Qiao","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2021.111342_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/2896809","article-title":"Possible involvement of liver resident macrophages (Kupffer cells) in the pathogenesis of both intrahepatic and extrahepatic inflammation","volume":"2017","author":"Kakinuma","year":"2017","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2021.111342_bib70","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cellimm.2017.12.007","article-title":"Dynamic plasticity of macrophage functions in diseased liver","volume":"330","author":"Ritz","year":"2018","journal-title":"Cell Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2021.111342_bib71","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/j.biomaterials.2013.01.033","article-title":"Multifunctional polymeric nanoparticles for oral delivery of TNF-alpha siRNA to macrophages","volume":"34","author":"He","year":"2013","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biopha.2021.111342_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10717544.2017.1399301","article-title":"Enhanced efficacy of curcumin with phosphatidylserine-decorated nanoparticles in the treatment of hepatic fibrosis","volume":"25","author":"Wang","year":"2018","journal-title":"Drug Deliv."},{"issue":"4","key":"10.1016\/j.biopha.2021.111342_bib73","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep.28973","article-title":"Hepatocyte autotaxin expression promotes liver fibrosis and cancer","volume":"65","author":"Kaffe","year":"2017","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.biopha.2021.111342_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044138","article-title":"A novel in vivo siRNA delivery system specifically targeting liver cells for protection of ConA-induced fulminant hepatitis","volume":"7","author":"Jiang","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2021.111342_bib75","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1124\/jpet.106.114215","article-title":"Hepatoprotective activity of liposomal flavonoid against arsenite-induced liver fibrosis","volume":"320","author":"Mandal","year":"2007","journal-title":"J. Pharm. Exp. Ther."},{"issue":"20","key":"10.1016\/j.biopha.2021.111342_bib76","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.3748\/wjg.v11.i20.3075","article-title":"Uptake of albumin nanoparticle surface modified with glycyrrhizin by primary cultured rat hepatocytes","volume":"11","author":"Mao","year":"2005","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.biopha.2021.111342_bib77","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41575-019-0146-6","article-title":"LSEC stretch promotes fibrosis during hepatic vascular congestion","volume":"16","author":"Thomas","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.biopha.2021.111342_bib78","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/hep.27376","article-title":"Liver sinusoidal endothelial cells in hepatic fibrosis","volume":"61","author":"DeLeve","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.biopha.2021.111342_bib79","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/s-0037-1617455","article-title":"Liver sinusoidal endothelial cell: an update","volume":"37","author":"DeLeve","year":"2017","journal-title":"Semin. Liver Dis."},{"issue":"1","key":"10.1016\/j.biopha.2021.111342_bib80","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jconrel.2010.11.008","article-title":"Evaluation of polyanion-coated biodegradable polymeric micelles as drug delivery vehicles","volume":"155","author":"Ohya","year":"2011","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.biopha.2021.111342_bib81","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1182\/blood-2012-11-468579","article-title":"Specific gene delivery to liver sinusoidal and artery endothelial cells","volume":"122","author":"Abel","year":"2013","journal-title":"Blood"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222100127X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222100127X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:27:25Z","timestamp":1760099245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222100127X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":81,"alternative-id":["S075333222100127X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111342","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in the research of nanodrug delivery system for targeted treatment of liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111342","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111342"}}